Sphera Encapsulation, a leader in advanced encapsulation technologies, and Hudson River Biotechnology (HRB) announced a strategic collaboration to patent an intelligent delivery particle. This innovative delivery system aims to revolutionize the drug delivery industry by offering advanced biotechnology solutions that address the challenges of targeted distribution and treatment efficacy.

An innovation for targeted delivery

Drug and biologic delivery is an ever-evolving field in the biotechnology landscape, but the difficulties in ensuring the precise and targeted release of active ingredients remain a significant obstacle. Traditional delivery systems cannot provide optimal distribution within plant cells and are not always biodegradable. This leads to a considerable waste of products and resources, consequently impacting the environment. Sphera Encapsulation and HRB have developed Plentrance™, a biodegradable and targeted particle designed to penetrate plant cell walls and deliver cargo into the cells to address this issue.

The Smart Delivery Particle: An Advanced Solution

The Smart Delivery Particle developed by Hudson River Biotechnology and Sphera Encapsulation is designed to improve the efficacy of agricultural and biotech treatments. Plentrance™ increases the bioavailability of active ingredients, ensuring that ingredients reach the right place and time to maximize effectiveness. Initially designed for CRISPR delivery as part of a gene editing system, this particle has also demonstrated unique potential for agricultural applications. Its encapsulation and targeted delivery characteristics make it a scalable, cost-effective, and highly customizable technology.

A positive impact on the environment and ecological agriculture

The technology for delivering drugs and biological compounds through Plentrance™ particles is compatible with ecological agriculture. Its use reduces product waste and lowers the environmental impact of treatments. Only a third of fertilizers and less than 0.1% of pesticides reach their target. The new technology promises to improve these numbers, significantly reducing costs and pollution from chemical runoff. This sustainable approach relieves pressure on natural ecosystems, contributing to a greener and more efficient future.

A step forward towards advanced biotechnological solutions

With the patenting of the Plentrance™ particle, Sphera Encapsulation and Hudson River Biotechnology (HRB) are making a fundamental contribution to advancing advanced biotechnological solutions. The newly developed particles easily integrate into existing workflows, offering producers and farmers a scalable and tailored solution. This enables greater treatment efficacy while reducing resource consumption and operating costs.

An innovative future for biotechnology and agriculture

The partnership between Sphera Encapsulation and Hudson River Biotechnology marks an essential milestone in the innovation of advanced biotechnology solutions. The intelligent delivery particle is set to transform the way drugs and agricultural treatments are administered, benefiting industry and the environment. This development confirms the two companies’ commitment to promoting sustainable and cutting-edge technologies, aiming for a future in which efficiency, precision, and sustainability are at the heart of agricultural and biotechnology practices.

To request more information on Sphera Encapsulation’s services and technologies, fill out the form on this page.

Follow us on our social channels:
LinkedIn
Facebook
Instagram